A detailed history of Pds Planning, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Pds Planning, Inc holds 113,274 shares of ABT stock, worth $11.8 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
113,274
Previous 113,455 0.16%
Holding current value
$11.8 Million
Previous $12.5 Million 3.1%
% of portfolio
1.36%
Previous 1.43%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$109.52 - $120.96 $19,823 - $21,893
-181 Reduced 0.16%
113,274 $12.9 Million
Q4 2023

Feb 01, 2024

BUY
$90.19 - $110.4 $36,076 - $44,160
400 Added 0.35%
113,455 $12.5 Million
Q3 2023

Oct 20, 2023

SELL
$95.53 - $114.62 $556,080 - $667,203
-5,821 Reduced 4.9%
113,055 $10.9 Million
Q2 2023

Jul 20, 2023

SELL
$100.78 - $112.29 $1.02 Million - $1.14 Million
-10,170 Reduced 7.88%
118,876 $13 Million
Q1 2023

May 01, 2023

BUY
$96.86 - $114.01 $138,606 - $163,148
1,431 Added 1.12%
129,046 $13.1 Million
Q4 2022

Jan 26, 2023

BUY
$95.06 - $111.52 $3,992 - $4,683
42 Added 0.03%
127,615 $0
Q3 2022

Nov 02, 2022

BUY
$96.76 - $112.03 $967 - $1,120
10 Added 0.01%
127,573 $12.3 Million
Q2 2022

Jul 15, 2022

BUY
$102.07 - $123.37 $5,205 - $6,291
51 Added 0.04%
127,563 $13.9 Million
Q1 2022

Apr 18, 2022

BUY
$114.02 - $139.04 $1.47 Million - $1.79 Million
12,880 Added 11.24%
127,512 $15.1 Million
Q4 2021

Jan 25, 2022

BUY
$115.53 - $141.46 $2.83 Million - $3.46 Million
24,454 Added 27.12%
114,632 $16.1 Million
Q3 2021

Oct 22, 2021

BUY
$116.66 - $129.06 $38,847 - $42,976
333 Added 0.37%
90,178 $10.7 Million
Q2 2021

Jul 26, 2021

SELL
$105.79 - $124.53 $214,013 - $251,924
-2,023 Reduced 2.2%
89,845 $10.4 Million
Q1 2021

Apr 20, 2021

BUY
$108.84 - $128.23 $98,391 - $115,919
904 Added 0.99%
91,868 $11 Million
Q4 2020

Jan 21, 2021

SELL
$105.0 - $114.42 $164,220 - $178,952
-1,564 Reduced 1.69%
90,964 $9.96 Million
Q3 2020

Oct 19, 2020

SELL
$91.64 - $111.29 $690,324 - $838,347
-7,533 Reduced 7.53%
92,528 $10.1 Million
Q2 2020

Aug 11, 2020

BUY
$76.57 - $98.0 $69,678 - $89,180
910 Added 0.92%
100,061 $9.15 Million
Q1 2020

Apr 20, 2020

BUY
$62.82 - $91.86 $115,400 - $168,746
1,837 Added 1.89%
99,151 $7.82 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $296,689 - $330,284
-3,779 Reduced 3.74%
97,314 $8.45 Million
Q3 2019

Oct 28, 2019

BUY
$81.84 - $88.74 $77,748 - $84,303
950 Added 0.95%
101,093 $8.46 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $70,110 - $81,770
962 Added 0.97%
100,143 $8.42 Million
Q1 2019

Apr 19, 2019

SELL
$66.22 - $80.06 $59,598 - $72,054
-900 Reduced 0.9%
99,181 $7.93 Million
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $54,808 - $62,089
-836 Reduced 0.83%
100,081 $7.24 Million
Q3 2018

Nov 02, 2018

BUY
$60.81 - $73.36 $2,675 - $3,227
44 Added 0.04%
100,917 $7.4 Million
Q2 2018

Jul 27, 2018

SELL
$57.57 - $63.54 $80,079 - $88,384
-1,391 Reduced 1.36%
100,873 $6.15 Million
Q1 2018

May 03, 2018

BUY
$56.27 - $63.62 $2,138 - $2,417
38 Added 0.04%
102,264 $6.13 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $5.49 Million - $5.87 Million
102,226
102,226 $5.83 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pds Planning, Inc Portfolio

Follow Pds Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.